AI & Medicine

This is a drastic change — from a reactive insurance model to a proactive one. These types of insurance models lean heavily on preventative care that is data- and genetic-driven through AI, and should be the path for the United States to be the healthiest country in the world. It will require both legislative incentives and politicians willing to lead the effort. Currently there are many preventative-care models, but most health insurance offered through companies still does not offer plans that understand the value of data- and genetic-driven preventative care.

Millions of dollars are being invested in medicine to further the advancement of pharmaceutical discoveries, CRISPR, models like AlphaFold, and many other sectors of the medical industry. These historic advancements in drug discovery have largely been the result of reinvestment in research by leading pharmaceutical companies. Because of the imminent revolution in medicine driven by AI, government has a renewed responsibility to ensure we change our health industry to reverse the increase of disease and health issues associated with trending data over the last 30-plus years.

The proposal

The following is a domestic policy proposal that can effectively help reverse the reactive application of medical insurance in the United States by passing legislation, policy, and supporting initiatives that incentivize proactive measures for insurance policies and penalize reactive insurance policies. Incentivizing and penalizing insurance will require a different approach to health — encouraging plans to keep us healthy through preventative measures like supplements, vitamins, and nutrients.

The arborist analogy

Ask yourself what an arborist does when a tree is ill or has a disease — they don’t find a medication to put on the diseased area. They often take a soil sample, determine what nutrients the tree is deficient in, and then add those nutrients to the soil.

Medicine desperately needs a transformation in all aspects. The current driver is big pharma and all medical industries making money by any means necessary to obtain it — even at the risk of the health of the individual. Across all sectors of medicine, the data reflects a serious decline in the average health of a human body. This natural effect has trended over decades and is highlighted by the influence on your elected politician by big donors, lobbyists, and their own political party.

Changing the reward system

The reward system is a recursive cycle of persuasion through money. From a top-down congressional perspective, almost everything should be encouraged through legislative persuasion — incentivize good behavior and penalize harmful behavior. As society ebbs and flows in its moral compass, this legislation might change. It is evident from the data that harm is occurring, and society collectively sees this as a prescription for change.

We have political parties controlling Congress who have been captured by activists, lobbyists, donors, or those with the time to contribute to their form of change. Because of the constraints put on the human family — both parents working, inflation, taxes, rearing children — we have an incursion of politicians who are more persuaded by their own careers, status, or financial increase than by their own constituents. This must change.

To change the medical industry’s motivation to exist, we must change the incentive structure. That means unbiased metrics should be contributing to their tax penalties instead of their peddling influence on our politicians. Many pharmaceuticals and prescriptions are taken orally and affect our gut biome — the first line of processing the nutrients the human body ingests, with effects on many processes throughout the body.

Where we start

This will entail actively supporting ideas to remove chemicals from agriculture, incentivizing the prevention of disease through natural remedies, and supporting small farmers and regenerative farming techniques. We propose legislation, policy, and initiatives to help change the current philosophy of the reactive medical industry. As an organization, we support the MAHA movement and implementing policy that will remove known poisons, carcinogenic chemicals, and other harmful methods and processes in our foods. This effort is initially focused through agriculture, big pharma, and small farmers.

Alignment with MAHA

Robert F. Kennedy Jr. champions substantial improvements in agriculture and medicine via his Make America Healthy Again (MAHA) initiative, highlighting the necessity of regenerative farming practices, the prohibition of detrimental chemicals, and the endorsement of small farmers. He advocates a transition to regenerative agriculture — soil health, biodiversity, and sustainability — asserting that existing agricultural policies favor huge corporate farms to the detriment of small and medium-sized family farms. Kennedy asserts that those family farms are essential for a robust food economy.

An essential component of his agenda is the eradication of harmful pesticides and chemicals from the food supply, which he claims are likely responsible for chronic health problems and environmental deterioration. He underscores the necessity of offering small farmers alternatives to detrimental agricultural techniques that jeopardize their economic sustainability and health, advocating for regulations that let them prosper without resorting to industrial farming models.

Alongside his agricultural initiatives, Kennedy has criticized the pharmaceutical sector, alleging that it prioritizes profits over public health. He seeks to amend health rules that permit pharmaceutical companies to take advantage of customers via exorbitant prescription pricing and dubious practices. The MAHA effort aims to address chronic diseases, which Kennedy attributes to inadequate nutrition and environmental contaminants intensified by agricultural methods and pharmacological interventions. His strategy encompasses the promotion of healthier lifestyles and the implementation of clearer food labels.

Kennedy’s views largely correspond with Donald Trump’s political agenda, especially on healthcare and agricultural issues. Once his nomination is confirmed as the head of the Department of Health and Human Services (HHS), he has indicated he will enact substantial reforms to combat the chronic disease epidemic in the U.S. This includes reforming dietary recommendations, diminishing subsidies for ultra-processed foods, and promoting augmented funding for sustainable agriculture. His government would likely prioritize public-health initiatives designed to educate Americans on nutrition and environmental contaminants, while advocating for the advantages of regenerative agriculture.